Cosmetics and personal care
Which rules apply to sun protection?
We track 6,810 rules for these in 20 of 21 markets, including California's Prop 65 list of 883 chemicals. Check your product free, no account needed.
- Free
- No account needed
- The law behind every rule
Cosmetics and personal care / Skin care / Sun protection
Sunscreens and sun-protection products. US: OTC drug (monograph M020) and a cosmetic only when the sun claim is secondary; EU/UK: cosmetic with Annex VI UV filters; KR/JP: functional cosmetic or quasi-drug.
Rules
Rules by market
Open a market to read its rules for this category.
Main sources, from 1 Jan 2025 · What is covered
United States (federal): main sources stored. Modelled: TSCA section 8(a)(7) PFAS reporting and recordkeeping (40 CFR 705), shown as applying only if the product contains a PFAS; FD&C Act ch. VI cosmetics as amended by MoCRA (21 U.S.C. 361-364j: adulteration, misbranding, adverse events, GMP, registration and listing, safety substantiation, labelling); 21 CFR 700, 701, 710, 720; 740 and color additive parts 73; OTC sunscreen: 21 CFR 201.327 labeling, SPF, broad-spectrum and water-resistance tests; 21 CFR 201.66 Drug Facts; 21 CFR part 207 establishment registration, drug listing and NDC; 74 and 82 where cosmetics are named. Not stored: OTC drug products other than sunscreen (antiperspirant M019, anti-dandruff, fluoride toothpaste M021); for sunscreen: the M020 list of permitted active ingredients and concentrations, and OMUFA facility fees; FPLA and 16 CFR 500 packaging rules; FDA GMP and talc-asbestos testing rules until final; color additive petition status after ClaraDB's data date; state law other than listed US states.
A non-toxic claim made for the product or its package.
Must meet the conditions of Do not misrepresent, directly or by implication, that the product, package or service is non-toxic. Qualify a non-toxic claim clearly and prominently to the extent necessary to avoid deception.
The start date is not stated in the text (date unknown).
Consolidated text (not the authentic legal edition), current to 20 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-20 per the eCFR.
- Claim: non-toxic
In force, start date unknown
The text states only the Federal Register publication date of the current Guides (October 11, 2012); it states no separate effective date.
“It is deceptive to misrepresent, directly or by implication, that a product, package, or service is non-toxic. Non-toxic claims should be clearly and prominently qualified to the extent necessary to avoid deception.”
A claim that the product or its package is free of PFAS or does not contain or use PFAS.
Must meet the conditions of A claim that the product is free of PFAS must be truthful and be clearly and prominently qualified to the extent necessary to avoid deception. Even a truthful claim may be deceptive if the product contains or uses substances that pose the same or similar environmental risks, or if PFAS has not been associated with the product category. A free-of claim can be appropriate for a trace amount only if the level is no more than an acknowledged trace contaminant or background level, its presence does not cause material harm that consumers typically associate with the substance, and it was not added intentionally. These Guides are the FTC's guidance on how Section 5 of the FTC Act applies to environmental claims; they do not ban the claim, but the FTC can act against a claim that is inconsistent with them.
The start date is not stated in the text (date unknown).
Consolidated text (not the authentic legal edition), current to 20 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-20 per the eCFR.
- Claim: PFAS-free
In force, start date unknown
The text states only the Federal Register publication date of the current Guides (October 11, 2012); it states no separate effective date.
“It is deceptive to misrepresent, directly or by implication, that a product, package, or service is free of, or does not contain or use, a substance.”
A claim that the product or its package is free of PTFE or does not contain or use PTFE.
Must meet the conditions of A claim that the product is free of PTFE must be truthful and be clearly and prominently qualified to the extent necessary to avoid deception. Even a truthful claim may be deceptive if the product contains or uses substances that pose the same or similar environmental risks, or if PTFE has not been associated with the product category. A free-of claim can be appropriate for a trace amount only if the level is no more than an acknowledged trace contaminant or background level, its presence does not cause material harm that consumers typically associate with the substance, and it was not added intentionally. These Guides are the FTC's guidance on how Section 5 of the FTC Act applies to environmental claims; they do not ban the claim, but the FTC can act against a claim that is inconsistent with them.
The start date is not stated in the text (date unknown).
Consolidated text (not the authentic legal edition), current to 20 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-20 per the eCFR.
- Claim: PTFE-free
In force, start date unknown
The text states only the Federal Register publication date of the current Guides (October 11, 2012); it states no separate effective date.
“It is deceptive to misrepresent, directly or by implication, that a product, package, or service is free of, or does not contain or use, a substance.”
A recyclable claim made for the product or its package.
Must meet the conditions of Market the item as recyclable only if it can be collected, separated or otherwise recovered from the waste stream through an established recycling program for reuse or for use in making another item. Make an unqualified claim only when recycling facilities are available to a substantial majority (at least 60 percent) of consumers or communities where the item is sold; otherwise qualify the claim. Qualify which portions are recyclable when only some components are, and do not call the item recyclable if any component, or its shape or size, significantly limits recycling. These Guides are the FTC's guidance on how Section 5 of the FTC Act applies to environmental claims; they do not ban the claim, but the FTC can act against a claim that is inconsistent with them.
The start date is not stated in the text (date unknown).
Consolidated text (not the authentic legal edition), current to 20 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-20 per the eCFR.
- Claim: recyclable
In force, start date unknown
The text states only the Federal Register publication date of the current Guides (October 11, 2012); it states no separate effective date.
“A product or package should not be marketed as recyclable unless it can be collected, separated, or otherwise recovered from the waste stream through an established recycling program”
A label that represents the product as Made in the United States without qualification.
Must meet the conditions of Label a product as Made in the United States only if its final assembly or processing occurs in the United States, all significant processing that goes into it occurs in the United States, and all or virtually all of its ingredients or components are made and sourced in the United States. The same applies to a seal, mark, tag or stamp in a mail order catalog or mail order promotional material. A violation is treated as a violation of a trade regulation rule under section 18 of the FTC Act.
The start date is not stated in the text (date unknown).
Consolidated text (not the authentic legal edition), current to 20 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-20 per the eCFR.
- Claim: Made in USA
In force, start date unknown
The text states only the Federal Register publication date of the rule (July 14, 2021); it states no separate effective date.
“all significant processing that goes into the product occurs in the United States, and all or virtually all ingredients or components of the product are made and sourced in the United States.”
If you give a written warranty, put all its terms in one clear document: who and what is covered, what you will do, how long, how to claim, and the required State-rights statements
Disclosure to buyer
Written warranty terms (16 CFR 701.3(a)): a warrantor who gives a written warranty on a consumer product costing the consumer more than $15.00 must clearly and conspicuously disclose, in a single document in simple and readily understood language: (1) who the warranty is extended to, if limited to the original purchaser or otherwise; (2) the products, parts or components covered and, where needed, excluded; (3) what the warrantor will do on a defect or failure, and what it will pay for or provide; (4) when the term starts if not on the purchase date, and how long it lasts; (5) step by step how to claim, with the warrantor's name and mailing address or responsible department, or a free telephone number; (6) any informal dispute settlement mechanism (part 703); (7) any limit on the duration of implied warranties, with "Some States do not allow limitations on how long an implied warranty lasts, so the above limitation may not apply to you."; (8) any exclusion or limit on incidental or consequential damages, with its State-law statement; (9) "This warranty gives you specific legal rights, and you may also have other rights which vary from State to State." If return of a registration card is a condition of coverage, the warranty must say so (701.4).
Exemptions (2)
Products bought solely for commercial or industrial use are excluded from this part; warranties that cover only a repairer's workmanship (services) are not covered by the Act (700.1(h)).
“Products which are purchased solely for commercial or industrial use are excluded solely for purposes of this part.”
Third-party emblems, seals or insignias promising replacement or refund, with no representation of quality or performance, are exempt from (a)(1)-(9) if the third party publishes the disclosures in each issue of a general-circulation publication and gives them free on written request.
“Paragraphs (a) (1) through (9) of this section shall not be applicable with respect to statements of general policy on emblems, seals or insignias issued by third parties promising replacement or refund if a consumer product is defective”
Consolidated text (not the authentic legal edition), current to 23 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; versioner date 2026-10-23.
- It is a consumer product (tangible personal property normally used for personal, family or household purposes) (16 CFR 701.1(b), 702.1(b))
- You give a written warranty on a consumer product that costs the consumer more than $15 (16 CFR 701.2: the rules apply to "written warranties on consumer products actually costing the consumer more than $15.00"; 701.1(h): a warrantor is "any supplier, manufacturer, or other person who gives or offers to give a written warranty")
In force since 1 Jan 1977
Applies to products manufactured on or after 1 Jan 1977
Parts 701 and 702 apply only to written warranties on products manufactured after December 31, 1976 (16 CFR 700.12); 702.3 was last revised at 81 FR 63669, Sept. 15, 2016 (online warranty terms option).
“Any warrantor warranting to a consumer by means of a written warranty a consumer product actually costing the consumer more than $15.00 shall clearly and conspicuously disclose in a single document in simple and readily understood language, the following items of information:”
Make the written warranty's text available to the buyer before the sale (in store, catalog or online listing, door to door); the warrantor supplies the text or posts it online
Disclosure to buyer
Pre-sale availability of written warranty terms (16 CFR 702.3), for consumer products costing the consumer more than $15.00. Seller (702.3(a)): make the warranty text readily available before sale by displaying it close to the product, or by furnishing it on request with signs telling buyers it is available. Catalog and mail order sellers, including any offer whose ordering does not need a visit to the seller (702.3(c)): give the full text, or the warrantor's web address plus where to request a free copy, beside the product description or in a referenced section. Door-to-door sellers: say before the sale that the warranties may be inspected (702.3(d)). Warrantor (702.3(b)(1)): give sellers the warranty materials (a copy with every product, a tag or label with the full text, the text on a display carton, or a sign or poster, with a copy in the box), and give catalog, mail order and door-to-door sellers copies; or (702.3(b)(2)) post the terms on its website, state the web address and a non-Internet way to request them in the manual or on the product or package, and send a free hard copy on request.
Exemptions (2)
Products bought solely for commercial or industrial use are excluded from this part; warranties that cover only a repairer's workmanship (services) are not covered by the Act (700.1(h)).
“Products which are purchased solely for commercial or industrial use are excluded solely for purposes of this part.”
Third-party emblems, seals or insignias promising replacement or refund, with no representation of quality or performance, are exempt from the in-store display duty (702.3(a)(1)) if the third party publishes the 701.3 disclosures and gives them free on written request.
“Paragraph (a)(1) of this section shall not be applicable with respect to statements of general policy on emblems, seals or insignias issued by third parties promising replacement or refund if a consumer product is defective”
Consolidated text (not the authentic legal edition), current to 23 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; versioner date 2026-10-23.
- It is a consumer product (tangible personal property normally used for personal, family or household purposes) (16 CFR 701.1(b), 702.1(b))
- You give a written warranty on a consumer product that costs the consumer more than $15, or sell such a product with one (16 CFR 702.3: "The following requirements apply to consumer products actually costing the consumer more than $15.00"; the seller's duties are in 702.3(a), the warrantor's in 702.3(b))
In force since 1 Jan 1977
Applies to products manufactured on or after 1 Jan 1977
Parts 701 and 702 apply only to written warranties on products manufactured after December 31, 1976 (16 CFR 700.12); 702.3 was last revised at 81 FR 63669, Sept. 15, 2016 (online warranty terms option).
“the seller of a consumer product with a written warranty shall make a text of the warranty readily available for examination by the prospective buyer by:”
Broad Spectrum SPF effectiveness statement on the principal display panel
Label required
Broad Spectrum SPF [insert numerical SPF value resulting from testing under paragraph (i) of this section]; Prominently placed on the principal display panel; continuous text with no intervening text or graphic; same font style, size and color with the same background color
Exemptions (1)
Not applicable to sunscreen products marketed under an approved new drug application (NDA) or abbreviated new drug application (ANDA).
“The provisions do not apply to sunscreen products marketed under approved new drug applications or abbreviated new drug applications.”
Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Claim: broad spectrum
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: otc drug claim
In force since 17 Jun 2011
Applies to products placed on the market on or after 17 Jun 2011
In force from 2011-06-17: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
For products that pass the broad spectrum test in paragraph (j) of this section. (A) The labeling states “Broad Spectrum SPF [insert numerical SPF value resulting from testing under paragraph (i) of this section]”.
Broad spectrum test (critical wavelength) before labeling Broad Spectrum
Test required
Broad spectrum test: in vitro UV spectrometry on PMMA plates after pre-irradiation; a mean critical wavelength of 370 nm or greater is broad spectrum protection (21 CFR 201.327(j))
Exemptions (1)
Not applicable to sunscreen products marketed under an approved new drug application (NDA) or abbreviated new drug application (ANDA).
“The provisions do not apply to sunscreen products marketed under approved new drug applications or abbreviated new drug applications.”
Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Claim: broad spectrum
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: otc drug claim
In force since 17 Jun 2011
Applies to products placed on the market on or after 17 Jun 2011
In force from 2011-06-17: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
“A mean critical wavelength of 370 nm or greater is classified as broad spectrum protection.”
9 rules from 21 CFR 201.327 Over-the-counter sunscreen drug products; required labeling based on effectiveness testing
Label required
Show targets (9 of 9)
- Application direction under the heading Directions
- Direction for children under 6 months under the heading Directions
- Storage statement under the heading Other information
- Reapplication direction for products that do not satisfy the water resistance test
- Skin Cancer/Skin Aging Alert as the first statement under Warnings
- SPF effectiveness statement on the principal display panel for products that do not pass the broad spectrum test
- Statement of identity: established name and identification as a sunscreen
- “Uses” statement: helps prevent sunburn
- Warnings required for all sunscreen products under the heading Warnings
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: otc drug claim
17 Jun 2011
Each rule has its own date; open a target.
Example: Application direction under the heading Directions
(ii) The labeling states “[bullet] apply [select one of the following: ‘Liberally’ or ‘generously’] [and, as an option: ‘And evenly’] 15 minutes before sun exposure”.
Reapplication direction for products that satisfy the water resistance test
Label required
[bullet] reapply: [Bullet] after [select one of the following determined by water resistance test: ‘40 minutes of’ or ‘80 minutes of’] swimming or sweating [bullet] immediately after towel drying [bullet] at least every 2 hours
Exemptions (1)
Not applicable to sunscreen products marketed under an approved new drug application (NDA) or abbreviated new drug application (ANDA).
“The provisions do not apply to sunscreen products marketed under approved new drug applications or abbreviated new drug applications.”
Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Claim: water resistant
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: otc drug claim
In force since 17 Jun 2011
Applies to products placed on the market on or after 17 Jun 2011
In force from 2011-06-17: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
For products that satisfy the water resistance test in paragraph (i)(7) of this section. The labeling states “[bullet] reapply: [Bullet] after [select one of the following determined by water resistance test: ‘40 minutes of’ or ‘80 minutes of’] swimming or sweating
Water resistance statement (40 minutes) on the principal display panel
Label required
Water Resistant (40 minutes)
Exemptions (1)
Not applicable to sunscreen products marketed under an approved new drug application (NDA) or abbreviated new drug application (ANDA).
“The provisions do not apply to sunscreen products marketed under approved new drug applications or abbreviated new drug applications.”
Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Claim: water resistant
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: otc drug claim
In force since 17 Jun 2011
Applies to products placed on the market on or after 17 Jun 2011
In force from 2011-06-17: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
For products that provide 40 minutes of water resistance according to the test in paragraph (i)(7)(i) of this section. The labeling states “Water Resistant (40 minutes)”.
Water resistance statement (80 minutes) on the principal display panel
Label required
Water Resistant (80 minutes)
Exemptions (1)
Not applicable to sunscreen products marketed under an approved new drug application (NDA) or abbreviated new drug application (ANDA).
“The provisions do not apply to sunscreen products marketed under approved new drug applications or abbreviated new drug applications.”
Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Claim: water resistant
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: otc drug claim
In force since 17 Jun 2011
Applies to products placed on the market on or after 17 Jun 2011
In force from 2011-06-17: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
For products that provide 80 minutes of water resistance according to the test in paragraph (i)(7)(ii) of this section. The labeling states “Water Resistant (80 minutes)”.
SPF determined by the SPF test procedure in 21 CFR 201.327(i)
Test required
Determine the labeled SPF value by the SPF test procedure (solar simulator, SPF standard, test panel of at least 10 valid subjects, MED determination) (21 CFR 201.327(i))
Exemptions (1)
Not applicable to sunscreen products marketed under an approved new drug application (NDA) or abbreviated new drug application (ANDA).
“The provisions do not apply to sunscreen products marketed under approved new drug applications or abbreviated new drug applications.”
Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: otc drug claim
In force since 17 Jun 2011
Applies to products placed on the market on or after 17 Jun 2011
In force from 2011-06-17: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
“Determine the labeled SPF value, which equals the largest whole number less than In order for the SPF determination of a test product to be considered valid, the SPF value of the SPF standard should fall within the standard deviation range of the expected SPF (i.e., 16.3 ±3.43).”
Sun Protection Measures direction for Broad Spectrum SPF 15 or higher
Label required
[bullet] Sun Protection Measures. [in bold font] Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: [Bullet] limit time in the sun, especially from 10 a.m.-2 p.m. [bullet] wear long-sleeved shirts, pants, hats, and sunglasses
Exemptions (1)
Not applicable to sunscreen products marketed under an approved new drug application (NDA) or abbreviated new drug application (ANDA).
“The provisions do not apply to sunscreen products marketed under approved new drug applications or abbreviated new drug applications.”
Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Claim: broad spectrum
- Labelled sun protection factor at least 15 SPF
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: spf claim, otc drug claim
In force since 17 Jun 2011
Applies to products placed on the market on or after 17 Jun 2011
In force from 2011-06-17: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
For sunscreen products with a Broad Spectrum SPF value of 15 or higher according to the tests in paragraphs (i) and (j) of this section. The labeling states “[bullet] Sun Protection Measures.
Water resistance test (40 or 80 minutes of water immersion) before a water resistance statement
Test required
Determine the labeled SPF after 40 minutes (or 80 minutes) of water immersion by the water resistance procedure (21 CFR 201.327(i)(7))
Exemptions (1)
Not applicable to sunscreen products marketed under an approved new drug application (NDA) or abbreviated new drug application (ANDA).
“The provisions do not apply to sunscreen products marketed under approved new drug applications or abbreviated new drug applications.”
Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Claim: water resistant
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: otc drug claim
In force since 17 Jun 2011
Applies to products placed on the market on or after 17 Jun 2011
In force from 2011-06-17: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
“The labeled SPF should be determined after 40 minutes of water immersion using the following procedure:”
11 rules from 21 CFR 201.66 Format and content requirements for over-the-counter (OTC) drug product labeling
Label required
Show targets (11 of 11)
- Active ingredients with established name and proportion (topicals)
- Drug Facts set off in a box with barlines and hairlines
- Bulleted statements under Uses, Warnings, Directions and Other information
- Drug Facts required headings in order
- No graphics or other information inside the Drug Facts labeling
- Drug Facts title at the top of the OTC drug labeling
- Drug Facts minimum type sizes
- Drug Facts type style, leading and color
- For external use only warning for topical drug products
- Inactive ingredients listed by established name
- “Keep out of reach of children” warning under Warnings
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: otc drug claim
17 Mar 1999
Each rule has its own date; open a target.
Example: Active ingredients with established name and proportion (topicals)
“products marketed without discrete dosage units (e.g., topicals) shall state the proportion (rather than the quantity) of each active ingredient.”
Review and update of drug listing information each June and December
Registration required
FDA drug listing: review and update each June and December (new drugs, discontinuations, resumptions, material changes, or a no-changes certification)
Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Your role: Manufacturer
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: economic operator role, otc drug claim
In force since 31 Aug 2016
Applies to products distributed on or after 31 Aug 2016
In force from 2016-08-31: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
“Registrants must review and update their drug listing information each June and December.”
Drug listing with FDA for each drug you manufacture, repack, relabel or salvage
Registration required
FDA drug listing: each registrant lists each drug it manufactures, repacks, relabels or salvages for commercial distribution, no later than 3 calendar days after initial registration of the establishment (for drugs made there at that time); a drug made for a private label distributor is listed under an NDC with that distributor's labeler code and, for human drugs, also under the registrant's own labeler code
Exemptions (1)
A foreign establishment need not register and list if its drugs enter a foreign trade zone and are re-exported without entering U.S. commerce, or are imported under FD&C Act section 801(d)(3).
“Their drugs enter a foreign trade zone and are re-exported without having entered U.S. commerce, or”
Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Your role: Manufacturer
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: economic operator role, otc drug claim
In force since 31 Aug 2016
Applies to products manufactured on or after 31 Aug 2016
In force from 2016-08-31: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
“Each registrant must list each drug that it manufactures, repacks, relabels, or salvages for commercial distribution.”
Annual review and update of establishment registration information
Registration required
FDA drug establishment registration: annual review and update between October 1 and December 31 of each calendar year (certify no changes if none)
Exemptions (1)
Private label distributors who do not also manufacture, repack, relabel, or salvage drugs are not required to register.
“Private label distributors who do not also manufacture, repack, relabel, or salvage drugs are not required to register under this part.”
Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Your role: Manufacturer
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: economic operator role, otc drug claim
In force since 31 Aug 2016
Applies to products manufactured on or after 31 Aug 2016
In force from 2016-08-31: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
“Subsequent reviews and updates must occur annually, during the period beginning on October 1 and ending December 31 of each calendar year.”
Register each establishment that manufactures, repacks or relabels the drug with FDA
Registration required
FDA drug establishment registration (electronic drug registration and listing system): each domestic establishment that manufactures, repacks, relabels or salvages the drug, no later than 5 calendar days after beginning those operations there
Exemptions (1)
Private label distributors who do not also manufacture, repack, relabel or salvage drugs are not required to register.
“Private label distributors who do not also manufacture, repack, relabel, or salvage drugs are not required to register under this part.”
Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Your role: Manufacturer
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: economic operator role, otc drug claim
In force since 31 Aug 2016
Applies to products manufactured on or after 31 Aug 2016
In force from 2016-08-31: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
“Registrants must register each domestic establishment no later than 5 calendar days after beginning to manufacture, repack, relabel, or salvage a drug”
NDC labeler code from FDA
Registration required
FDA NDC labeler code: each person who manufactures, repacks, relabels or is the private label distributor of a drug subject to listing applies for a labeler code (electronically) and updates the information within 30 calendar days of any change
Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Your role: Manufacturer
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: economic operator role, otc drug claim
In force since 31 Aug 2016
Applies to products manufactured on or after 31 Aug 2016
In force from 2016-08-31: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
“Each person who engages in manufacturing, repacking, relabeling, or private label distribution of a drug subject to listing under this part must apply for an NDC labeler code”
Foreign drug establishment registration
Registration required
FDA drug establishment registration (electronic drug registration and listing system): each foreign establishment that manufactures, repacks, relabels or salvages the drug, before the drug is imported or offered for import into the United States
Exemptions (2)
Private label distributors who do not also manufacture, repack, relabel or salvage drugs are not required to register.
“Private label distributors who do not also manufacture, repack, relabel, or salvage drugs are not required to register under this part.”
A foreign establishment need not register and list if its drugs enter a foreign trade zone and are re-exported without entering U.S. commerce, or are imported under FD&C Act section 801(d)(3).
“Their drugs enter a foreign trade zone and are re-exported without having entered U.S. commerce, or”
Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Your role: Manufacturer
- Imported into the market of sale
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: economic operator role, imported, otc drug claim
In force since 31 Aug 2016
Applies to products imported on or after 31 Aug 2016
In force from 2016-08-31: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
“Registrants must register each foreign establishment before a drug or an animal feed bearing or containing a new animal drug manufactured, repacked, relabeled, or salvaged at the establishment is imported or offered for import into the United States.”
Unique National Drug Code (NDC) for each listed finished drug product
Registration required
National Drug Code (NDC): unique 10- or 11-digit code identifying labeler, product, and package size and type, proposed with the listing and assigned by FDA
Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: otc drug claim
In force since 31 Aug 2016
Applies to products distributed on or after 31 Aug 2016
In force from 2016-08-31: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
“Each finished drug product or unfinished drug subject to the listing requirements of this part must have a unique NDC to identify its labeler, product, and package size and type.”
Self-pressurized containers warning
Label required
Warning—Avoid spraying in eyes. Contents under pressure. Do not puncture or incinerate. Do not store at temperature above 120 °F. Keep out of reach of children.
Consolidated text (not the authentic legal edition), current to 7 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-07 per the eCFR.
- Sold in a pressurised aerosol can
- Makes a drug claim (for example sunscreen or anti-dandruff): no
Depends on: aerosol dispenser, otc drug claim
In force since 3 Mar 1975
Applies to products placed on the market on or after 3 Mar 1975
In force from 1975-03-03: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
“Warning—Avoid spraying in eyes. Contents under pressure. Do not puncture or incinerate. Do not store at temperature above 120 °F. Keep out of reach of children.”
- Conformity
A non-toxic claim made for the product or its package.
Must meet the conditions of Do not misrepresent, directly or by implication, that the product, package or service is non-toxic. Qualify a non-toxic claim clearly and prominently to the extent necessary to avoid deception.
The start date is not stated in the text (date unknown).
Consolidated text (not the authentic legal edition), current to 20 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-20 per the eCFR.
- Applies when
- Claim: non-toxic
- Effective
In force, start date unknown
The text states only the Federal Register publication date of the current Guides (October 11, 2012); it states no separate effective date.
- Source
“It is deceptive to misrepresent, directly or by implication, that a product, package, or service is non-toxic. Non-toxic claims should be clearly and prominently qualified to the extent necessary to avoid deception.”
§260.10(a) · fetched 2026-10-22US FTC via eCFR: 16 CFR 260.10(opens in a new tab)
- Conformity
A claim that the product or its package is free of PFAS or does not contain or use PFAS.
Must meet the conditions of A claim that the product is free of PFAS must be truthful and be clearly and prominently qualified to the extent necessary to avoid deception. Even a truthful claim may be deceptive if the product contains or uses substances that pose the same or similar environmental risks, or if PFAS has not been associated with the product category. A free-of claim can be appropriate for a trace amount only if the level is no more than an acknowledged trace contaminant or background level, its presence does not cause material harm that consumers typically associate with the substance, and it was not added intentionally. These Guides are the FTC's guidance on how Section 5 of the FTC Act applies to environmental claims; they do not ban the claim, but the FTC can act against a claim that is inconsistent with them.
The start date is not stated in the text (date unknown).
Consolidated text (not the authentic legal edition), current to 20 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-20 per the eCFR.
- Applies when
- Claim: PFAS-free
- Effective
In force, start date unknown
The text states only the Federal Register publication date of the current Guides (October 11, 2012); it states no separate effective date.
- Source
“It is deceptive to misrepresent, directly or by implication, that a product, package, or service is free of, or does not contain or use, a substance.”
§260.9(a) · fetched 2026-10-22US FTC via eCFR: 16 CFR 260.9(opens in a new tab)
- Conformity
A claim that the product or its package is free of PTFE or does not contain or use PTFE.
Must meet the conditions of A claim that the product is free of PTFE must be truthful and be clearly and prominently qualified to the extent necessary to avoid deception. Even a truthful claim may be deceptive if the product contains or uses substances that pose the same or similar environmental risks, or if PTFE has not been associated with the product category. A free-of claim can be appropriate for a trace amount only if the level is no more than an acknowledged trace contaminant or background level, its presence does not cause material harm that consumers typically associate with the substance, and it was not added intentionally. These Guides are the FTC's guidance on how Section 5 of the FTC Act applies to environmental claims; they do not ban the claim, but the FTC can act against a claim that is inconsistent with them.
The start date is not stated in the text (date unknown).
Consolidated text (not the authentic legal edition), current to 20 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-20 per the eCFR.
- Applies when
- Claim: PTFE-free
- Effective
In force, start date unknown
The text states only the Federal Register publication date of the current Guides (October 11, 2012); it states no separate effective date.
- Source
“It is deceptive to misrepresent, directly or by implication, that a product, package, or service is free of, or does not contain or use, a substance.”
§260.9(a) · fetched 2026-10-22US FTC via eCFR: 16 CFR 260.9(opens in a new tab)
- Conformity
A recyclable claim made for the product or its package.
Must meet the conditions of Market the item as recyclable only if it can be collected, separated or otherwise recovered from the waste stream through an established recycling program for reuse or for use in making another item. Make an unqualified claim only when recycling facilities are available to a substantial majority (at least 60 percent) of consumers or communities where the item is sold; otherwise qualify the claim. Qualify which portions are recyclable when only some components are, and do not call the item recyclable if any component, or its shape or size, significantly limits recycling. These Guides are the FTC's guidance on how Section 5 of the FTC Act applies to environmental claims; they do not ban the claim, but the FTC can act against a claim that is inconsistent with them.
The start date is not stated in the text (date unknown).
Consolidated text (not the authentic legal edition), current to 20 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-20 per the eCFR.
- Applies when
- Claim: recyclable
- Effective
In force, start date unknown
The text states only the Federal Register publication date of the current Guides (October 11, 2012); it states no separate effective date.
- Source
“A product or package should not be marketed as recyclable unless it can be collected, separated, or otherwise recovered from the waste stream through an established recycling program”
§260.12(a) (excerpt) · fetched 2026-10-22US FTC via eCFR: 16 CFR 260.12(opens in a new tab)
- Conformity
A label that represents the product as Made in the United States without qualification.
Must meet the conditions of Label a product as Made in the United States only if its final assembly or processing occurs in the United States, all significant processing that goes into it occurs in the United States, and all or virtually all of its ingredients or components are made and sourced in the United States. The same applies to a seal, mark, tag or stamp in a mail order catalog or mail order promotional material. A violation is treated as a violation of a trade regulation rule under section 18 of the FTC Act.
The start date is not stated in the text (date unknown).
Consolidated text (not the authentic legal edition), current to 20 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-20 per the eCFR.
- Applies when
- Claim: Made in USA
- Effective
In force, start date unknown
The text states only the Federal Register publication date of the rule (July 14, 2021); it states no separate effective date.
- Source
“all significant processing that goes into the product occurs in the United States, and all or virtually all ingredients or components of the product are made and sourced in the United States.”
§323.2 (excerpt) · fetched 2026-10-22US FTC via eCFR: 16 CFR 323.2(opens in a new tab)
- Disclosure
If you give a written warranty, put all its terms in one clear document: who and what is covered, what you will do, how long, how to claim, and the required State-rights statements
Disclosure to buyer
Written warranty terms (16 CFR 701.3(a)): a warrantor who gives a written warranty on a consumer product costing the consumer more than $15.00 must clearly and conspicuously disclose, in a single document in simple and readily understood language: (1) who the warranty is extended to, if limited to the original purchaser or otherwise; (2) the products, parts or components covered and, where needed, excluded; (3) what the warrantor will do on a defect or failure, and what it will pay for or provide; (4) when the term starts if not on the purchase date, and how long it lasts; (5) step by step how to claim, with the warrantor's name and mailing address or responsible department, or a free telephone number; (6) any informal dispute settlement mechanism (part 703); (7) any limit on the duration of implied warranties, with "Some States do not allow limitations on how long an implied warranty lasts, so the above limitation may not apply to you."; (8) any exclusion or limit on incidental or consequential damages, with its State-law statement; (9) "This warranty gives you specific legal rights, and you may also have other rights which vary from State to State." If return of a registration card is a condition of coverage, the warranty must say so (701.4).
Exemptions (2)
Products bought solely for commercial or industrial use are excluded from this part; warranties that cover only a repairer's workmanship (services) are not covered by the Act (700.1(h)).
“Products which are purchased solely for commercial or industrial use are excluded solely for purposes of this part.”
16 CFR 701.1(b) · fetched 2026-10-27US FTC via eCFR: 15 U.S.C. 2301 ff.; 16 CFR 700.1, 701.2, 701.3, 702.3(opens in a new tab) Third-party emblems, seals or insignias promising replacement or refund, with no representation of quality or performance, are exempt from (a)(1)-(9) if the third party publishes the disclosures in each issue of a general-circulation publication and gives them free on written request.
“Paragraphs (a) (1) through (9) of this section shall not be applicable with respect to statements of general policy on emblems, seals or insignias issued by third parties promising replacement or refund if a consumer product is defective”
16 CFR 701.3(b) (excerpt) · fetched 2026-10-27US FTC via eCFR: 15 U.S.C. 2301 ff.; 16 CFR 700.1, 701.2, 701.3, 702.3(opens in a new tab) Consolidated text (not the authentic legal edition), current to 23 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; versioner date 2026-10-23.
- Applies when
- It is a consumer product (tangible personal property normally used for personal, family or household purposes) (16 CFR 701.1(b), 702.1(b))
- You give a written warranty on a consumer product that costs the consumer more than $15 (16 CFR 701.2: the rules apply to "written warranties on consumer products actually costing the consumer more than $15.00"; 701.1(h): a warrantor is "any supplier, manufacturer, or other person who gives or offers to give a written warranty")
- Effective
In force since 1 Jan 1977
Applies to products manufactured on or after 1 Jan 1977
Parts 701 and 702 apply only to written warranties on products manufactured after December 31, 1976 (16 CFR 700.12); 702.3 was last revised at 81 FR 63669, Sept. 15, 2016 (online warranty terms option).
- Source
“Any warrantor warranting to a consumer by means of a written warranty a consumer product actually costing the consumer more than $15.00 shall clearly and conspicuously disclose in a single document in simple and readily understood language, the following items of information:”
16 CFR 701.3(a) · fetched 2026-10-27US FTC via eCFR: 15 U.S.C. 2301 ff.; 16 CFR 700.1, 701.2, 701.3, 702.3(opens in a new tab)
- Disclosure
Make the written warranty's text available to the buyer before the sale (in store, catalog or online listing, door to door); the warrantor supplies the text or posts it online
Disclosure to buyer
Pre-sale availability of written warranty terms (16 CFR 702.3), for consumer products costing the consumer more than $15.00. Seller (702.3(a)): make the warranty text readily available before sale by displaying it close to the product, or by furnishing it on request with signs telling buyers it is available. Catalog and mail order sellers, including any offer whose ordering does not need a visit to the seller (702.3(c)): give the full text, or the warrantor's web address plus where to request a free copy, beside the product description or in a referenced section. Door-to-door sellers: say before the sale that the warranties may be inspected (702.3(d)). Warrantor (702.3(b)(1)): give sellers the warranty materials (a copy with every product, a tag or label with the full text, the text on a display carton, or a sign or poster, with a copy in the box), and give catalog, mail order and door-to-door sellers copies; or (702.3(b)(2)) post the terms on its website, state the web address and a non-Internet way to request them in the manual or on the product or package, and send a free hard copy on request.
Exemptions (2)
Products bought solely for commercial or industrial use are excluded from this part; warranties that cover only a repairer's workmanship (services) are not covered by the Act (700.1(h)).
“Products which are purchased solely for commercial or industrial use are excluded solely for purposes of this part.”
16 CFR 702.1(b) · fetched 2026-10-27US FTC via eCFR: 15 U.S.C. 2301 ff.; 16 CFR 700.1, 701.2, 701.3, 702.3(opens in a new tab) Third-party emblems, seals or insignias promising replacement or refund, with no representation of quality or performance, are exempt from the in-store display duty (702.3(a)(1)) if the third party publishes the 701.3 disclosures and gives them free on written request.
“Paragraph (a)(1) of this section shall not be applicable with respect to statements of general policy on emblems, seals or insignias issued by third parties promising replacement or refund if a consumer product is defective”
16 CFR 702.3(b)(3) (excerpt) · fetched 2026-10-27US FTC via eCFR: 15 U.S.C. 2301 ff.; 16 CFR 700.1, 701.2, 701.3, 702.3(opens in a new tab) Consolidated text (not the authentic legal edition), current to 23 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; versioner date 2026-10-23.
- Applies when
- It is a consumer product (tangible personal property normally used for personal, family or household purposes) (16 CFR 701.1(b), 702.1(b))
- You give a written warranty on a consumer product that costs the consumer more than $15, or sell such a product with one (16 CFR 702.3: "The following requirements apply to consumer products actually costing the consumer more than $15.00"; the seller's duties are in 702.3(a), the warrantor's in 702.3(b))
- Effective
In force since 1 Jan 1977
Applies to products manufactured on or after 1 Jan 1977
Parts 701 and 702 apply only to written warranties on products manufactured after December 31, 1976 (16 CFR 700.12); 702.3 was last revised at 81 FR 63669, Sept. 15, 2016 (online warranty terms option).
- Source
“the seller of a consumer product with a written warranty shall make a text of the warranty readily available for examination by the prospective buyer by:”
16 CFR 702.3(a) (excerpt) · fetched 2026-10-27US FTC via eCFR: 15 U.S.C. 2301 ff.; 16 CFR 700.1, 701.2, 701.3, 702.3(opens in a new tab)
- Label
Broad Spectrum SPF effectiveness statement on the principal display panel
Label required
Broad Spectrum SPF [insert numerical SPF value resulting from testing under paragraph (i) of this section]; Prominently placed on the principal display panel; continuous text with no intervening text or graphic; same font style, size and color with the same background color
Exemptions (1)
Not applicable to sunscreen products marketed under an approved new drug application (NDA) or abbreviated new drug application (ANDA).
“The provisions do not apply to sunscreen products marketed under approved new drug applications or abbreviated new drug applications.”
21 CFR 201.327 (introductory text) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR 201.327(opens in a new tab) Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Applies when
- Claim: broad spectrum
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: otc drug claim
- Effective
In force since 17 Jun 2011
Applies to products placed on the market on or after 17 Jun 2011
In force from 2011-06-17: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
- Source
For products that pass the broad spectrum test in paragraph (j) of this section. (A) The labeling states “Broad Spectrum SPF [insert numerical SPF value resulting from testing under paragraph (i) of this section]”.
21 CFR 201.327(a)(1)(i) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR 201.327(opens in a new tab)
- Test
Broad spectrum test (critical wavelength) before labeling Broad Spectrum
Test required
Broad spectrum test: in vitro UV spectrometry on PMMA plates after pre-irradiation; a mean critical wavelength of 370 nm or greater is broad spectrum protection (21 CFR 201.327(j))
Exemptions (1)
Not applicable to sunscreen products marketed under an approved new drug application (NDA) or abbreviated new drug application (ANDA).
“The provisions do not apply to sunscreen products marketed under approved new drug applications or abbreviated new drug applications.”
21 CFR 201.327 (introductory text) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR 201.327(opens in a new tab) Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Applies when
- Claim: broad spectrum
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: otc drug claim
- Effective
In force since 17 Jun 2011
Applies to products placed on the market on or after 17 Jun 2011
In force from 2011-06-17: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
- Source
“A mean critical wavelength of 370 nm or greater is classified as broad spectrum protection.”
21 CFR 201.327(j)(7) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR 201.327(opens in a new tab)
- Label x 9
9 rules from 21 CFR 201.327 Over-the-counter sunscreen drug products; required labeling based on effectiveness testing
Label required
Show targets (9 of 9)
- Application direction under the heading Directions
- Direction for children under 6 months under the heading Directions
- Storage statement under the heading Other information
- Reapplication direction for products that do not satisfy the water resistance test
- Skin Cancer/Skin Aging Alert as the first statement under Warnings
- SPF effectiveness statement on the principal display panel for products that do not pass the broad spectrum test
- Statement of identity: established name and identification as a sunscreen
- “Uses” statement: helps prevent sunburn
- Warnings required for all sunscreen products under the heading Warnings
- Applies when
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: otc drug claim
- Effective
17 Jun 2011
Each rule has its own date; open a target.
- Source
Example: Application direction under the heading Directions
(ii) The labeling states “[bullet] apply [select one of the following: ‘Liberally’ or ‘generously’] [and, as an option: ‘And evenly’] 15 minutes before sun exposure”.
21 CFR 201.327(e)(1)(ii) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR 201.327(opens in a new tab)
- Label
Reapplication direction for products that satisfy the water resistance test
Label required
[bullet] reapply: [Bullet] after [select one of the following determined by water resistance test: ‘40 minutes of’ or ‘80 minutes of’] swimming or sweating [bullet] immediately after towel drying [bullet] at least every 2 hours
Exemptions (1)
Not applicable to sunscreen products marketed under an approved new drug application (NDA) or abbreviated new drug application (ANDA).
“The provisions do not apply to sunscreen products marketed under approved new drug applications or abbreviated new drug applications.”
21 CFR 201.327 (introductory text) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR 201.327(opens in a new tab) Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Applies when
- Claim: water resistant
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: otc drug claim
- Effective
In force since 17 Jun 2011
Applies to products placed on the market on or after 17 Jun 2011
In force from 2011-06-17: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
- Source
For products that satisfy the water resistance test in paragraph (i)(7) of this section. The labeling states “[bullet] reapply: [Bullet] after [select one of the following determined by water resistance test: ‘40 minutes of’ or ‘80 minutes of’] swimming or sweating
21 CFR 201.327(e)(3) (excerpt) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR 201.327(opens in a new tab)
- Label
Water resistance statement (40 minutes) on the principal display panel
Label required
Water Resistant (40 minutes)
Exemptions (1)
Not applicable to sunscreen products marketed under an approved new drug application (NDA) or abbreviated new drug application (ANDA).
“The provisions do not apply to sunscreen products marketed under approved new drug applications or abbreviated new drug applications.”
21 CFR 201.327 (introductory text) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR 201.327(opens in a new tab) Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Applies when
- Claim: water resistant
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: otc drug claim
- Effective
In force since 17 Jun 2011
Applies to products placed on the market on or after 17 Jun 2011
In force from 2011-06-17: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
- Source
For products that provide 40 minutes of water resistance according to the test in paragraph (i)(7)(i) of this section. The labeling states “Water Resistant (40 minutes)”.
21 CFR 201.327(a)(2)(i) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR 201.327(opens in a new tab)
- Label
Water resistance statement (80 minutes) on the principal display panel
Label required
Water Resistant (80 minutes)
Exemptions (1)
Not applicable to sunscreen products marketed under an approved new drug application (NDA) or abbreviated new drug application (ANDA).
“The provisions do not apply to sunscreen products marketed under approved new drug applications or abbreviated new drug applications.”
21 CFR 201.327 (introductory text) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR 201.327(opens in a new tab) Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Applies when
- Claim: water resistant
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: otc drug claim
- Effective
In force since 17 Jun 2011
Applies to products placed on the market on or after 17 Jun 2011
In force from 2011-06-17: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
- Source
For products that provide 80 minutes of water resistance according to the test in paragraph (i)(7)(ii) of this section. The labeling states “Water Resistant (80 minutes)”.
21 CFR 201.327(a)(2)(ii) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR 201.327(opens in a new tab)
- Test
SPF determined by the SPF test procedure in 21 CFR 201.327(i)
Test required
Determine the labeled SPF value by the SPF test procedure (solar simulator, SPF standard, test panel of at least 10 valid subjects, MED determination) (21 CFR 201.327(i))
Exemptions (1)
Not applicable to sunscreen products marketed under an approved new drug application (NDA) or abbreviated new drug application (ANDA).
“The provisions do not apply to sunscreen products marketed under approved new drug applications or abbreviated new drug applications.”
21 CFR 201.327 (introductory text) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR 201.327(opens in a new tab) Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Applies when
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: otc drug claim
- Effective
In force since 17 Jun 2011
Applies to products placed on the market on or after 17 Jun 2011
In force from 2011-06-17: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
- Source
“Determine the labeled SPF value, which equals the largest whole number less than In order for the SPF determination of a test product to be considered valid, the SPF value of the SPF standard should fall within the standard deviation range of the expected SPF (i.e., 16.3 ±3.43).”
21 CFR 201.327(i)(6)(ii) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR 201.327(opens in a new tab)
- Label
Sun Protection Measures direction for Broad Spectrum SPF 15 or higher
Label required
[bullet] Sun Protection Measures. [in bold font] Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: [Bullet] limit time in the sun, especially from 10 a.m.-2 p.m. [bullet] wear long-sleeved shirts, pants, hats, and sunglasses
Exemptions (1)
Not applicable to sunscreen products marketed under an approved new drug application (NDA) or abbreviated new drug application (ANDA).
“The provisions do not apply to sunscreen products marketed under approved new drug applications or abbreviated new drug applications.”
21 CFR 201.327 (introductory text) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR 201.327(opens in a new tab) Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Applies when
- Claim: broad spectrum
- Labelled sun protection factor at least 15 SPF
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: spf claim, otc drug claim
- Effective
In force since 17 Jun 2011
Applies to products placed on the market on or after 17 Jun 2011
In force from 2011-06-17: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
- Source
For sunscreen products with a Broad Spectrum SPF value of 15 or higher according to the tests in paragraphs (i) and (j) of this section. The labeling states “[bullet] Sun Protection Measures.
21 CFR 201.327(e)(2) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR 201.327(opens in a new tab)
- Test
Water resistance test (40 or 80 minutes of water immersion) before a water resistance statement
Test required
Determine the labeled SPF after 40 minutes (or 80 minutes) of water immersion by the water resistance procedure (21 CFR 201.327(i)(7))
Exemptions (1)
Not applicable to sunscreen products marketed under an approved new drug application (NDA) or abbreviated new drug application (ANDA).
“The provisions do not apply to sunscreen products marketed under approved new drug applications or abbreviated new drug applications.”
21 CFR 201.327 (introductory text) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR 201.327(opens in a new tab) Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Applies when
- Claim: water resistant
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: otc drug claim
- Effective
In force since 17 Jun 2011
Applies to products placed on the market on or after 17 Jun 2011
In force from 2011-06-17: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
- Source
“The labeled SPF should be determined after 40 minutes of water immersion using the following procedure:”
21 CFR 201.327(i)(7)(i) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR 201.327(opens in a new tab)
- Label x 11
11 rules from 21 CFR 201.66 Format and content requirements for over-the-counter (OTC) drug product labeling
Label required
Show targets (11 of 11)
- Active ingredients with established name and proportion (topicals)
- Drug Facts set off in a box with barlines and hairlines
- Bulleted statements under Uses, Warnings, Directions and Other information
- Drug Facts required headings in order
- No graphics or other information inside the Drug Facts labeling
- Drug Facts title at the top of the OTC drug labeling
- Drug Facts minimum type sizes
- Drug Facts type style, leading and color
- For external use only warning for topical drug products
- Inactive ingredients listed by established name
- “Keep out of reach of children” warning under Warnings
- Applies when
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: otc drug claim
- Effective
17 Mar 1999
Each rule has its own date; open a target.
- Source
Example: Active ingredients with established name and proportion (topicals)
“products marketed without discrete dosage units (e.g., topicals) shall state the proportion (rather than the quantity) of each active ingredient.”
21 CFR 201.66(c)(2) (excerpt) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR 201.66(opens in a new tab)
- Registration
Review and update of drug listing information each June and December
Registration required
FDA drug listing: review and update each June and December (new drugs, discontinuations, resumptions, material changes, or a no-changes certification)
Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Applies when
- Your role: Manufacturer
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: economic operator role, otc drug claim
- Effective
In force since 31 Aug 2016
Applies to products distributed on or after 31 Aug 2016
In force from 2016-08-31: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
- Source
“Registrants must review and update their drug listing information each June and December.”
21 CFR 207.57(b) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR 207(opens in a new tab)
- Registration
Drug listing with FDA for each drug you manufacture, repack, relabel or salvage
Registration required
FDA drug listing: each registrant lists each drug it manufactures, repacks, relabels or salvages for commercial distribution, no later than 3 calendar days after initial registration of the establishment (for drugs made there at that time); a drug made for a private label distributor is listed under an NDC with that distributor's labeler code and, for human drugs, also under the registrant's own labeler code
Exemptions (1)
A foreign establishment need not register and list if its drugs enter a foreign trade zone and are re-exported without entering U.S. commerce, or are imported under FD&C Act section 801(d)(3).
“Their drugs enter a foreign trade zone and are re-exported without having entered U.S. commerce, or”
21 CFR 207.13(j) (excerpt) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR Part 207(opens in a new tab) Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Applies when
- Your role: Manufacturer
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: economic operator role, otc drug claim
- Effective
In force since 31 Aug 2016
Applies to products manufactured on or after 31 Aug 2016
In force from 2016-08-31: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
- Source
“Each registrant must list each drug that it manufactures, repacks, relabels, or salvages for commercial distribution.”
21 CFR 207.41(a); 207.45 · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR Part 207(opens in a new tab)
- Registration
Annual review and update of establishment registration information
Registration required
FDA drug establishment registration: annual review and update between October 1 and December 31 of each calendar year (certify no changes if none)
Exemptions (1)
Private label distributors who do not also manufacture, repack, relabel, or salvage drugs are not required to register.
“Private label distributors who do not also manufacture, repack, relabel, or salvage drugs are not required to register under this part.”
21 CFR 207.17(b) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR 207(opens in a new tab) Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Applies when
- Your role: Manufacturer
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: economic operator role, otc drug claim
- Effective
In force since 31 Aug 2016
Applies to products manufactured on or after 31 Aug 2016
In force from 2016-08-31: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
- Source
“Subsequent reviews and updates must occur annually, during the period beginning on October 1 and ending December 31 of each calendar year.”
21 CFR 207.29(b)(1) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR 207(opens in a new tab)
- Registration
Register each establishment that manufactures, repacks or relabels the drug with FDA
Registration required
FDA drug establishment registration (electronic drug registration and listing system): each domestic establishment that manufactures, repacks, relabels or salvages the drug, no later than 5 calendar days after beginning those operations there
Exemptions (1)
Private label distributors who do not also manufacture, repack, relabel or salvage drugs are not required to register.
“Private label distributors who do not also manufacture, repack, relabel, or salvage drugs are not required to register under this part.”
21 CFR 207.17(b) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR Part 207(opens in a new tab) Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Applies when
- Your role: Manufacturer
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: economic operator role, otc drug claim
- Effective
In force since 31 Aug 2016
Applies to products manufactured on or after 31 Aug 2016
In force from 2016-08-31: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
- Source
“Registrants must register each domestic establishment no later than 5 calendar days after beginning to manufacture, repack, relabel, or salvage a drug”
21 CFR 207.17(a); 207.21(a) (excerpt) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR Part 207(opens in a new tab)
- Registration
NDC labeler code from FDA
Registration required
FDA NDC labeler code: each person who manufactures, repacks, relabels or is the private label distributor of a drug subject to listing applies for a labeler code (electronically) and updates the information within 30 calendar days of any change
Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Applies when
- Your role: Manufacturer
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: economic operator role, otc drug claim
- Effective
In force since 31 Aug 2016
Applies to products manufactured on or after 31 Aug 2016
In force from 2016-08-31: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
- Source
“Each person who engages in manufacturing, repacking, relabeling, or private label distribution of a drug subject to listing under this part must apply for an NDC labeler code”
21 CFR 207.33(c)(1) (excerpt) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR Part 207(opens in a new tab)
- Registration
Foreign drug establishment registration
Registration required
FDA drug establishment registration (electronic drug registration and listing system): each foreign establishment that manufactures, repacks, relabels or salvages the drug, before the drug is imported or offered for import into the United States
Exemptions (2)
Private label distributors who do not also manufacture, repack, relabel or salvage drugs are not required to register.
“Private label distributors who do not also manufacture, repack, relabel, or salvage drugs are not required to register under this part.”
21 CFR 207.17(b) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR Part 207(opens in a new tab) A foreign establishment need not register and list if its drugs enter a foreign trade zone and are re-exported without entering U.S. commerce, or are imported under FD&C Act section 801(d)(3).
“Their drugs enter a foreign trade zone and are re-exported without having entered U.S. commerce, or”
21 CFR 207.13(j) (excerpt) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR Part 207(opens in a new tab) Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Applies when
- Your role: Manufacturer
- Imported into the market of sale
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: economic operator role, imported, otc drug claim
- Effective
In force since 31 Aug 2016
Applies to products imported on or after 31 Aug 2016
In force from 2016-08-31: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
- Source
“Registrants must register each foreign establishment before a drug or an animal feed bearing or containing a new animal drug manufactured, repacked, relabeled, or salvaged at the establishment is imported or offered for import into the United States.”
21 CFR 207.17(a); 207.21(b) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR Part 207(opens in a new tab)
- Registration
Unique National Drug Code (NDC) for each listed finished drug product
Registration required
National Drug Code (NDC): unique 10- or 11-digit code identifying labeler, product, and package size and type, proposed with the listing and assigned by FDA
Consolidated text (not the authentic legal edition), current to 1 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-01 per the eCFR.
- Applies when
- Makes a drug claim (for example sunscreen or anti-dandruff)
Depends on: otc drug claim
- Effective
In force since 31 Aug 2016
Applies to products distributed on or after 31 Aug 2016
In force from 2016-08-31: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
- Source
“Each finished drug product or unfinished drug subject to the listing requirements of this part must have a unique NDC to identify its labeler, product, and package size and type.”
21 CFR 207.33(a) · fetched 2026-10-11US National Archives / Office of the Federal Register (eCFR): 21 CFR 207(opens in a new tab)
- Label
Self-pressurized containers warning
Label required
Warning—Avoid spraying in eyes. Contents under pressure. Do not puncture or incinerate. Do not store at temperature above 120 °F. Keep out of reach of children.
Consolidated text (not the authentic legal edition), current to 7 Oct 2026. eCFR is an editorial compilation of the CFR, not the official legal edition; current to 2026-10-07 per the eCFR.
- Applies when
- Sold in a pressurised aerosol can
- Makes a drug claim (for example sunscreen or anti-dandruff): no
Depends on: aerosol dispenser, otc drug claim
- Effective
In force since 3 Mar 1975
Applies to products placed on the market on or after 3 Mar 1975
In force from 1975-03-03: the stored source note gives the Federal Register publication of the section text; no separate commencement date is stated.
- Source
“Warning—Avoid spraying in eyes. Contents under pressure. Do not puncture or incinerate. Do not store at temperature above 120 °F. Keep out of reach of children.”
21 CFR 740.11(a)(1) · fetched 2026-10-09US National Archives / Office of the Federal Register (eCFR): 21 CFR 700-740(opens in a new tab)
Gaps
Markets without rules for this category
We have no rules for this category in these markets. That doesn't mean none apply, so a check here says Not covered, never clear.
ClaraDB gives a verdict only for PFAS state laws for cookware and bakeware, California Proposition 65 consumer-product warning check for BPA, BPS, formaldehyde, styrene, antimony trioxide, vinyl acetate, lead and cadmium, California Proposition 65 warning check for candles and ceramicware (lead, cadmium, formaldehyde, acetaldehyde, benzene, naphthalene, carbon monoxide, benzo[a]pyrene), US packaging EPR producer size thresholds (California, Colorado, Maryland, Minnesota, Oregon, Washington) for a brand-owning manufacturer, US lead in children's products and furniture (lead paint and total lead content), US lead in toys and child care articles (lead paint and total lead content), US lead in children's products (other) and bags (lead paint and total lead content), US phthalates in children's toys and child care articles (DEHP, DBP, BBP, DINP, DIBP, DPENP, DHEXP, DCHP) and US children's product certificate and tracking label for children's tableware (AI-checked, quotes verified word for word). Every other answer shows the laws and quotes found without saying whether they apply. Not checked: Consumer electronics (FCC equipment authorization, 47 CFR Parts 2 and 15, energy rules). What ClaraDB has checked
Show 1 market
- Coverage
- Main sources; no modeled rule is scoped to this category. Not covered: other rules that may apply.
Facts
What we need to know about your product
Some rules depend on details of your product. Until you tell us, a check says Needs answers and asks for what's missing.
Show 31 facts
- Whether the listed substance or group is present
- Markets
- EU, GB, JP, KR, US, US-CA, US-CO, US-CT, US-IL, US-MD, US-ME, US-MN, US-NJ, US-RI, US-VT, US-WA
- Rules
- 7,475
- Number of employees at the seller
- Markets
- US-CA
- Rules
- 972
- Body area
- Markets
- EU, GB, JP, KR
- Rules
- 230
- Rinse off
- Markets
- EU, GB, JP, KR, US-CA
- Rules
- 221
- Economic operator role
- Markets
- EU, GB, KR, US
- Rules
- 96
- Otc drug claim
- Markets
- US, US-MN
- Rules
- 58
- Contains battery
- Markets
- EU, GB, US
- Rules
- 39
- Sprayable
- Markets
- EU, GB, KR
- Rules
- 34
- Intended for children under 3
- Markets
- EU, GB, KR
- Rules
- 24
- Battery category
- Markets
- EU, GB
- Rules
- 22
- Quasi drug or functional claim
- Markets
- JP, KR
- Rules
- 13
- Net content ml
- Markets
- EU, GB, KR
- Rules
- 10
- Battery chemistry
- Markets
- US
- Rules
- 9
- Aerosol dispenser
- Markets
- JP, KR, US
- Rules
- 8
- Professional use
- Markets
- EU, GB, US
- Rules
- 7
- Customised cosmetic
- Markets
- KR
- Rules
- 7
- Rechargeable
- Markets
- US
- Rules
- 6
- Animal testing conducted
- Markets
- EU, GB, KR
- Rules
- 5
- Contains nanomaterial
- Markets
- EU, GB
- Rules
- 2
- Intended for children under 12
- Markets
- KR
- Rules
- 2
- Single use
- Markets
- KR
- Rules
- 2
- Imported
- Markets
- KR, US
- Rules
- 2
- Button or coin cell
- Markets
- US
- Rules
- 2
- Distance sale to other member state
- Markets
- EU
- Rules
- 1
- Spf claim
- Markets
- US
- Rules
- 1
- Cattle derived material
- Markets
- US
- Rules
- 1
- Uses sunscreen term
- Markets
- US
- Rules
- 1
- Safety substantiated
- Markets
- US
- Rules
- 1
- Battery removable
- Markets
- US
- Rules
- 1
- Ca gross sales usd
- Markets
- US-CA
- Rules
- 1
- Fluorine treated container
- Markets
- US-VT
- Rules
- 1
Changes
Upcoming changes
Rules for this category that start in the next 24 months, or are proposed or on hold.
Show 41 upcoming changes
Warning required when exposure exceeds the threshold (no NSRL listed for this row)
This product can expose you to N-Methyl-N-Formylhydrazine, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov.
Exemptions (1)
No warning is required where the exposure poses no significant risk of cancer (at or below the NSRL).
a warning is not required if the business causing the exposure can demonstrate that the exposure occurs at a level that poses “no significant risk
Official text, current to 31 Jul 2026. OEHHA's own Prop 65 list (XLSX), list dated July 31, 2026.
- Seller has 10 or more employees
- Your business has 10 or more employees and the product knowingly and intentionally exposes someone in California to this chemical
Depends on: number of employees at the seller
Takes effect 8 Dec 2026
Applies to products sold on or after 8 Dec 2026
Listed 2025-12-08 (cancer). Grace period: "Proposition 65 warning requirements do not apply until 12 months after the chemical has been listed" (Appendix A); listing date plus 12 months.
- Chemical
- N-Methyl-N-Formylhydrazine
- Type of toxicity
- cancer
- Listed by
- the State's Qualified Experts (SQE)
- CAS No.
- 758-17-8
- Date listed
- 8 Dec 2025
Prop 65 list row: N-Methyl-N-Formylhydrazine · fetched 2026-10-08
California OEHHA: 27 CCR 27001(opens in a new tab)Warning required when exposure exceeds the threshold (no MADL listed for this row)
This product can expose you to Bisphenol S (BPS), which is known to the State of California to cause birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov.
Exemptions (1)
No warning is required for a reproductive toxicant where the exposure will produce no observable effect at 1,000 times the level in question (at or below the MADL).
“a warning is not required if the business causing the exposure can demonstrate that the exposure will produce no observable effect, even at 1,000 times the level in question.”
Official text, current to 31 Jul 2026. OEHHA's own Prop 65 list (XLSX), list dated July 31, 2026.
- Seller has 10 or more employees
- Your business has 10 or more employees and the product knowingly and intentionally exposes someone in California to this chemical
Depends on: number of employees at the seller
Takes effect 8 Dec 2026
Applies to products sold on or after 8 Dec 2026
Listed 2025-12-08 (developmental). Grace period: "Proposition 65 warning requirements do not apply until 12 months after the chemical has been listed" (Appendix A); listing date plus 12 months.
- Chemical
- Bisphenol S (BPS)
- Type of toxicity
- developmental toxicity
- Listed by
- the State's Qualified Experts (SQE)
- CAS No.
- 80-09-1
- Date listed
- 8 Dec 2025
Prop 65 list row: Bisphenol S (BPS) · fetched 2026-10-08
California OEHHA: 27 CCR 27001(opens in a new tab)Warning required when exposure exceeds the threshold (no NSRL listed for this row)
This product can expose you to Tacrolimus, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov.
Exemptions (1)
No warning is required where the exposure poses no significant risk of cancer (at or below the NSRL).
a warning is not required if the business causing the exposure can demonstrate that the exposure occurs at a level that poses “no significant risk
Official text, current to 31 Jul 2026. OEHHA's own Prop 65 list (XLSX), list dated July 31, 2026.
- Seller has 10 or more employees
- Your business has 10 or more employees and the product knowingly and intentionally exposes someone in California to this chemical
Depends on: number of employees at the seller
Takes effect 17 Jul 2027
Applies to products sold on or after 17 Jul 2027
Listed 2026-07-17 (cancer). Grace period: "Proposition 65 warning requirements do not apply until 12 months after the chemical has been listed" (Appendix A); listing date plus 12 months.
- Chemical
- Tacrolimus
- Type of toxicity
- cancer
- Listed by
- the Labor Code (LC)
- CAS No.
- 104987-11-3
- Date listed
- 17 Jul 2026
Prop 65 list row: Tacrolimus · fetched 2026-10-08
California OEHHA: 27 CCR 27001(opens in a new tab)Warning required when exposure exceeds the threshold (no NSRL listed for this row)
This product can expose you to Hydrochlorothiazide, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov.
Exemptions (1)
No warning is required where the exposure poses no significant risk of cancer (at or below the NSRL).
a warning is not required if the business causing the exposure can demonstrate that the exposure occurs at a level that poses “no significant risk
Official text, current to 31 Jul 2026. OEHHA's own Prop 65 list (XLSX), list dated July 31, 2026.
- Seller has 10 or more employees
- Your business has 10 or more employees and the product knowingly and intentionally exposes someone in California to this chemical
Depends on: number of employees at the seller
Takes effect 17 Jul 2027
Applies to products sold on or after 17 Jul 2027
Listed 2026-07-17 (cancer). Grace period: "Proposition 65 warning requirements do not apply until 12 months after the chemical has been listed" (Appendix A); listing date plus 12 months.
- Chemical
- Hydrochlorothiazide
- Type of toxicity
- cancer
- Listed by
- the Labor Code (LC)
- CAS No.
- 58-93-5; 125727-50-6; 8049-49-8
- Date listed
- 17 Jul 2026
Prop 65 list row: Hydrochlorothiazide · fetched 2026-10-08
California OEHHA: 27 CCR 27001(opens in a new tab)Warning required when exposure exceeds the threshold (no NSRL listed for this row)
This product can expose you to Voriconazole, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov.
Exemptions (1)
No warning is required where the exposure poses no significant risk of cancer (at or below the NSRL).
a warning is not required if the business causing the exposure can demonstrate that the exposure occurs at a level that poses “no significant risk
Official text, current to 31 Jul 2026. OEHHA's own Prop 65 list (XLSX), list dated July 31, 2026.
- Seller has 10 or more employees
- Your business has 10 or more employees and the product knowingly and intentionally exposes someone in California to this chemical
Depends on: number of employees at the seller
Takes effect 17 Jul 2027
Applies to products sold on or after 17 Jul 2027
Listed 2026-07-17 (cancer). Grace period: "Proposition 65 warning requirements do not apply until 12 months after the chemical has been listed" (Appendix A); listing date plus 12 months.
- Chemical
- Voriconazole
- Type of toxicity
- cancer
- Listed by
- the Labor Code (LC)
- CAS No.
- 137234-62-9; 188416-29-7; 173967-54-9
- Date listed
- 17 Jul 2026
Prop 65 list row: Voriconazole · fetched 2026-10-08
California OEHHA: 27 CCR 27001(opens in a new tab)Warning required when exposure exceeds the threshold (no NSRL listed for this row)
This product can expose you to Welding Fumes, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov.
Exemptions (1)
No warning is required where the exposure poses no significant risk of cancer (at or below the NSRL).
a warning is not required if the business causing the exposure can demonstrate that the exposure occurs at a level that poses “no significant risk
Official text, current to 31 Jul 2026. OEHHA's own Prop 65 list (XLSX), list dated July 31, 2026.
- Seller has 10 or more employees
- Your business has 10 or more employees and the product knowingly and intentionally exposes someone in California to this chemical
Depends on: number of employees at the seller
Takes effect 17 Jul 2027
Applies to products sold on or after 17 Jul 2027
Listed 2026-07-17 (cancer). Grace period: "Proposition 65 warning requirements do not apply until 12 months after the chemical has been listed" (Appendix A); listing date plus 12 months.
- Chemical
- Welding Fumes
- Type of toxicity
- cancer
- Listed by
- the Labor Code (LC)
- CAS No.
- none given
- Date listed
- 17 Jul 2026
Prop 65 list row: Welding Fumes · fetched 2026-10-08
California OEHHA: 27 CCR 27001(opens in a new tab)Banned
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
Every product in the category
Takes effect 1 Jan 2027
Applies to products placed on the market on or after 1 Jan 2027
Row footnote: products containing the substance shall not be placed on the Union market from 2027-01-01 and not be made available from 2028-07-01. The row-level date is read from the annex footnote (EU).
From the consolidated text: Triphenyl Phosphate (13) · 115-86-6 · 204-112-2
Annex II entry 1767 · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)Limit 0.7 % (content basis)
In the finished (ready for use) cosmetic product. Maximum concentration cell: (f) 0,7 %. Field of application: (f) Body lotion.
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applied to: Body
Depends on: body area
Takes effect 1 Jan 2027
Applies to products placed on the market on or after 1 Jan 2027
Row footnote: products containing the substance shall not be placed on the Union market from 2027-01-01 and not be made available from 2028-07-01. The row-level date is read from the annex footnote (EU).
From the consolidated text: (f) Body lotion · (f) 0,7 %
Annex III entry 75 (l5) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)11 rules from Regulation (EC) No 1223/2009 on cosmetic products, Annexes II-VI (consolidated)
Limit 0.2 % (content basis)
Show targets (11 of 11)
- Benzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
- Benzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
- Diethylamino Hydroxybenzoyl Hexyl Benzoate (DHHB) (Benzoic acid, 2-[4-(diethylamino)-2- hydroxybenzoyl]-, hexyl ester; CAS 302776-68-7)
- Citral Geranial (CAS 5392-40-5)
- Citral Geranial (CAS 5392-40-5)
- Zinc Acetate (CAS 557-34-6)
- Acetylated Vetiveria Zizanioides Root Extract (Vetiveria zizanioides, ext., acetylated Oils, vetiver, acetylated; CAS 84082-84-8)
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
Every product in the category
1 Jan 2027
Each rule has its own date; open a target.
Example: Benzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
From the consolidated text: (g) Face make-up and make-up remover products · (g) 0,2 %
Annex III entry 75 (l6) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)Limit 0.004 % (content basis)
In the finished (ready for use) cosmetic product. Maximum concentration cell: (h) 0,004 %. Field of application: (h) Oral products.
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applied to: Mouth or Teeth and gums
Depends on: body area
Takes effect 1 Jan 2027
Applies to products placed on the market on or after 1 Jan 2027
Row footnote: products containing the substance shall not be placed on the Union market from 2027-01-01 and not be made available from 2028-07-01. The row-level date is read from the annex footnote (EU).
From the consolidated text: (h) Oral products · (h) 0,004 %
Annex III entry 75 (l7) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)- WarningUS-CAN-Methyl-N-Formylhydrazine (CAS 758-17-8)
Warning required when exposure exceeds the threshold (no NSRL listed for this row)
This product can expose you to N-Methyl-N-Formylhydrazine, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov.
Exemptions (1)
No warning is required where the exposure poses no significant risk of cancer (at or below the NSRL).
a warning is not required if the business causing the exposure can demonstrate that the exposure occurs at a level that poses “no significant risk
Appendix A (summary), Exposures that pose no significant risk of cancer (excerpt) · fetched 2026-10-08California OAG / OEHHA: 27 CCR 27001(opens in a new tab) Official text, current to 31 Jul 2026. OEHHA's own Prop 65 list (XLSX), list dated July 31, 2026.
- Applies when
- Seller has 10 or more employees
- Your business has 10 or more employees and the product knowingly and intentionally exposes someone in California to this chemical
Depends on: number of employees at the seller
- Effective
Takes effect 8 Dec 2026
Applies to products sold on or after 8 Dec 2026
Listed 2025-12-08 (cancer). Grace period: "Proposition 65 warning requirements do not apply until 12 months after the chemical has been listed" (Appendix A); listing date plus 12 months.
- Source
- Chemical
- N-Methyl-N-Formylhydrazine
- Type of toxicity
- cancer
- Listed by
- the State's Qualified Experts (SQE)
- CAS No.
- 758-17-8
- Date listed
- 8 Dec 2025
Prop 65 list row: N-Methyl-N-Formylhydrazine · fetched 2026-10-08
California OEHHA: 27 CCR 27001(opens in a new tab)
- WarningUS-CABisphenol S (BPS) (CAS 80-09-1)
Warning required when exposure exceeds the threshold (no MADL listed for this row)
This product can expose you to Bisphenol S (BPS), which is known to the State of California to cause birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov.
Exemptions (1)
No warning is required for a reproductive toxicant where the exposure will produce no observable effect at 1,000 times the level in question (at or below the MADL).
“a warning is not required if the business causing the exposure can demonstrate that the exposure will produce no observable effect, even at 1,000 times the level in question.”
Appendix A (summary), Exposures that will produce no observable reproductive effect (excerpt) · fetched 2026-10-08California OAG / OEHHA: 27 CCR 27001(opens in a new tab) Official text, current to 31 Jul 2026. OEHHA's own Prop 65 list (XLSX), list dated July 31, 2026.
- Applies when
- Seller has 10 or more employees
- Your business has 10 or more employees and the product knowingly and intentionally exposes someone in California to this chemical
Depends on: number of employees at the seller
- Effective
Takes effect 8 Dec 2026
Applies to products sold on or after 8 Dec 2026
Listed 2025-12-08 (developmental). Grace period: "Proposition 65 warning requirements do not apply until 12 months after the chemical has been listed" (Appendix A); listing date plus 12 months.
- Source
- Chemical
- Bisphenol S (BPS)
- Type of toxicity
- developmental toxicity
- Listed by
- the State's Qualified Experts (SQE)
- CAS No.
- 80-09-1
- Date listed
- 8 Dec 2025
Prop 65 list row: Bisphenol S (BPS) · fetched 2026-10-08
California OEHHA: 27 CCR 27001(opens in a new tab)
- WarningUS-CATacrolimus (CAS 104987-11-3)
Warning required when exposure exceeds the threshold (no NSRL listed for this row)
This product can expose you to Tacrolimus, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov.
Exemptions (1)
No warning is required where the exposure poses no significant risk of cancer (at or below the NSRL).
a warning is not required if the business causing the exposure can demonstrate that the exposure occurs at a level that poses “no significant risk
Appendix A (summary), Exposures that pose no significant risk of cancer (excerpt) · fetched 2026-10-08California OAG / OEHHA: 27 CCR 27001(opens in a new tab) Official text, current to 31 Jul 2026. OEHHA's own Prop 65 list (XLSX), list dated July 31, 2026.
- Applies when
- Seller has 10 or more employees
- Your business has 10 or more employees and the product knowingly and intentionally exposes someone in California to this chemical
Depends on: number of employees at the seller
- Effective
Takes effect 17 Jul 2027
Applies to products sold on or after 17 Jul 2027
Listed 2026-07-17 (cancer). Grace period: "Proposition 65 warning requirements do not apply until 12 months after the chemical has been listed" (Appendix A); listing date plus 12 months.
- Source
- Chemical
- Tacrolimus
- Type of toxicity
- cancer
- Listed by
- the Labor Code (LC)
- CAS No.
- 104987-11-3
- Date listed
- 17 Jul 2026
Prop 65 list row: Tacrolimus · fetched 2026-10-08
California OEHHA: 27 CCR 27001(opens in a new tab)
- WarningUS-CAHydrochlorothiazide
Warning required when exposure exceeds the threshold (no NSRL listed for this row)
This product can expose you to Hydrochlorothiazide, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov.
Exemptions (1)
No warning is required where the exposure poses no significant risk of cancer (at or below the NSRL).
a warning is not required if the business causing the exposure can demonstrate that the exposure occurs at a level that poses “no significant risk
Appendix A (summary), Exposures that pose no significant risk of cancer (excerpt) · fetched 2026-10-08California OAG / OEHHA: 27 CCR 27001(opens in a new tab) Official text, current to 31 Jul 2026. OEHHA's own Prop 65 list (XLSX), list dated July 31, 2026.
- Applies when
- Seller has 10 or more employees
- Your business has 10 or more employees and the product knowingly and intentionally exposes someone in California to this chemical
Depends on: number of employees at the seller
- Effective
Takes effect 17 Jul 2027
Applies to products sold on or after 17 Jul 2027
Listed 2026-07-17 (cancer). Grace period: "Proposition 65 warning requirements do not apply until 12 months after the chemical has been listed" (Appendix A); listing date plus 12 months.
- Source
- Chemical
- Hydrochlorothiazide
- Type of toxicity
- cancer
- Listed by
- the Labor Code (LC)
- CAS No.
- 58-93-5; 125727-50-6; 8049-49-8
- Date listed
- 17 Jul 2026
Prop 65 list row: Hydrochlorothiazide · fetched 2026-10-08
California OEHHA: 27 CCR 27001(opens in a new tab)
- WarningUS-CAVoriconazole
Warning required when exposure exceeds the threshold (no NSRL listed for this row)
This product can expose you to Voriconazole, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov.
Exemptions (1)
No warning is required where the exposure poses no significant risk of cancer (at or below the NSRL).
a warning is not required if the business causing the exposure can demonstrate that the exposure occurs at a level that poses “no significant risk
Appendix A (summary), Exposures that pose no significant risk of cancer (excerpt) · fetched 2026-10-08California OAG / OEHHA: 27 CCR 27001(opens in a new tab) Official text, current to 31 Jul 2026. OEHHA's own Prop 65 list (XLSX), list dated July 31, 2026.
- Applies when
- Seller has 10 or more employees
- Your business has 10 or more employees and the product knowingly and intentionally exposes someone in California to this chemical
Depends on: number of employees at the seller
- Effective
Takes effect 17 Jul 2027
Applies to products sold on or after 17 Jul 2027
Listed 2026-07-17 (cancer). Grace period: "Proposition 65 warning requirements do not apply until 12 months after the chemical has been listed" (Appendix A); listing date plus 12 months.
- Source
- Chemical
- Voriconazole
- Type of toxicity
- cancer
- Listed by
- the Labor Code (LC)
- CAS No.
- 137234-62-9; 188416-29-7; 173967-54-9
- Date listed
- 17 Jul 2026
Prop 65 list row: Voriconazole · fetched 2026-10-08
California OEHHA: 27 CCR 27001(opens in a new tab)
- WarningUS-CAWelding Fumes
Warning required when exposure exceeds the threshold (no NSRL listed for this row)
This product can expose you to Welding Fumes, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov.
Exemptions (1)
No warning is required where the exposure poses no significant risk of cancer (at or below the NSRL).
a warning is not required if the business causing the exposure can demonstrate that the exposure occurs at a level that poses “no significant risk
Appendix A (summary), Exposures that pose no significant risk of cancer (excerpt) · fetched 2026-10-08California OAG / OEHHA: 27 CCR 27001(opens in a new tab) Official text, current to 31 Jul 2026. OEHHA's own Prop 65 list (XLSX), list dated July 31, 2026.
- Applies when
- Seller has 10 or more employees
- Your business has 10 or more employees and the product knowingly and intentionally exposes someone in California to this chemical
Depends on: number of employees at the seller
- Effective
Takes effect 17 Jul 2027
Applies to products sold on or after 17 Jul 2027
Listed 2026-07-17 (cancer). Grace period: "Proposition 65 warning requirements do not apply until 12 months after the chemical has been listed" (Appendix A); listing date plus 12 months.
- Source
- Chemical
- Welding Fumes
- Type of toxicity
- cancer
- Listed by
- the Labor Code (LC)
- CAS No.
- none given
- Date listed
- 17 Jul 2026
Prop 65 list row: Welding Fumes · fetched 2026-10-08
California OEHHA: 27 CCR 27001(opens in a new tab)
- BanEUTriphenyl Phosphate (CAS 115-86-6)
Banned
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applies when
Every product in the category
- Effective
Takes effect 1 Jan 2027
Applies to products placed on the market on or after 1 Jan 2027
Row footnote: products containing the substance shall not be placed on the Union market from 2027-01-01 and not be made available from 2028-07-01. The row-level date is read from the annex footnote (EU).
- Source
From the consolidated text: Triphenyl Phosphate (13) · 115-86-6 · 204-112-2
Annex II entry 1767 · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
- LimitEUBenzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
Limit 0.7 % (content basis)
In the finished (ready for use) cosmetic product. Maximum concentration cell: (f) 0,7 %. Field of application: (f) Body lotion.
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applies when
- Applied to: Body
Depends on: body area
- Effective
Takes effect 1 Jan 2027
Applies to products placed on the market on or after 1 Jan 2027
Row footnote: products containing the substance shall not be placed on the Union market from 2027-01-01 and not be made available from 2028-07-01. The row-level date is read from the annex footnote (EU).
- Source
From the consolidated text: (f) Body lotion · (f) 0,7 %
Annex III entry 75 (l5) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
- Limit x 11EU
11 rules from Regulation (EC) No 1223/2009 on cosmetic products, Annexes II-VI (consolidated)
Limit 0.2 % (content basis)
Show targets (11 of 11)
- Benzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
- Benzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
- Diethylamino Hydroxybenzoyl Hexyl Benzoate (DHHB) (Benzoic acid, 2-[4-(diethylamino)-2- hydroxybenzoyl]-, hexyl ester; CAS 302776-68-7)
- Citral Geranial (CAS 5392-40-5)
- Citral Geranial (CAS 5392-40-5)
- Zinc Acetate (CAS 557-34-6)
- Acetylated Vetiveria Zizanioides Root Extract (Vetiveria zizanioides, ext., acetylated Oils, vetiver, acetylated; CAS 84082-84-8)
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Applies when
Every product in the category
- Effective
1 Jan 2027
Each rule has its own date; open a target.
- Source
Example: Benzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
From the consolidated text: (g) Face make-up and make-up remover products · (g) 0,2 %
Annex III entry 75 (l6) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
- LimitEUBenzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
Limit 0.004 % (content basis)
In the finished (ready for use) cosmetic product. Maximum concentration cell: (h) 0,004 %. Field of application: (h) Oral products.
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applies when
- Applied to: Mouth or Teeth and gums
Depends on: body area
- Effective
Takes effect 1 Jan 2027
Applies to products placed on the market on or after 1 Jan 2027
Row footnote: products containing the substance shall not be placed on the Union market from 2027-01-01 and not be made available from 2028-07-01. The row-level date is read from the annex footnote (EU).
- Source
From the consolidated text: (h) Oral products · (h) 0,004 %
Annex III entry 75 (l7) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
Records
Recalls and alerts
Recalls, safety alerts and Prop 65 notices that name Sun protection, with a link to the original. A Prop 65 notice is a claim by the sender, not a ruling.
89 records dated 27 Jan 2023 to 4 Sep 2026. Most recent shown.
Show the 8 most recent records
- Safety Gate alerts
Sun screen - Aqua Sun Pa+++ SPF 90 Collagen Sunscreen Cream
Origin as stated: People's Republic of China
Cosmetics and personal care
- Substance
- None named
- Party
- Not stated
- Category
- Sun protection
- Safety Gate alerts
Sun screen - Innovation Anthelios UVmune 400 Fluide Oil Control
Origin as stated: People's Republic of China
Cosmetics and personal care
- Substance
- None named
- Party
- Not stated
- Category
- Sun protection
- Safety Gate alerts
Sun protection cream - Ultra Protect SPF 90+ Dry Touch Sunblock
Origin as stated: People's Republic of China
Cosmetics and personal care
- Substance
- None named
- Party
- Not stated
- Category
- Sun protection
- Safety Gate alerts
Sunscreen - Sunsreen Lotion
Origin as stated: People's Republic of China
Cosmetics and personal care
- Substance
- None named
- Party
- Not stated
- Category
- Sun protection
- Prop 65 notices
ThinkKids Zinc Oxide Sunscreen SPF 50 , ThinkKids Clear Zinc 20% Sunscreen SPF 30
Cosmetics and personal care
- Substance
- Lead
- Party
- Think Operations, LLC
- Category
- Sun protection
- Prop 65 notices
Sunscreen
Cosmetics and personal care
- Substance
- Benzophenone
- Party
- Kao USA Inc., Mario Badescu Skin Care, Inc., Chanel, Inc., Sol De Janeiro USA, Inc., Elizabeth Arden, Inc., Revlon Consumer Products LLC, CP Skin Health Group, Inc., Elta MD, Inc., Elta MD Holdings, Inc., Colgate-Palmolive Company, Murad, LLC, Unilever United States, Inc, Unilever Manufacturing (US), LLC, Glossier, Inc., Clarins USA, Inc., Clarins Group North America, Inc., Tonymoly USA LLC, Tonymoly Co., Ltd, Byoma US Inc., Byoma Limited, Sun Bum LLC, Sun Bum Suncare LLC, Ulta Salon, Cosmetics & Fragrance, Inc.
- Category
- Sun protection
- Safety Gate alerts
Sunscreen - Organic Babycare Baby & Kids Suncream 50
Origin as stated: Austria
Cosmetics and personal care
- Substance
- None named
- Party
- Not stated
- Category
- Sun protection
- Safety Gate alerts
Sunscreen - fresh baby sunscreen high SPF 50
Origin as stated: Austria
Cosmetics and personal care
- Substance
- None named
- Party
- Not stated
- Category
- Sun protectionBaby care
See also
Related categories
- Skin care
Face and body skin products, sun protection and exfoliants.
- Leave-on skin care
Creams, lotions, serums, oils and balms for face and body that stay on the skin (EU: leave-on product).
- Rinse-off skin cleansers
Face and body cleansers, scrubs and washes removed after application.
- Exfoliating acids and peels
AHA, BHA and similar chemical peels and exfoliants, general and professional use (EU Annex III splits limits by general and professional use).
Alerts
Get an email when these rules change.
Check a product free, no account needed. Save it, and you see when a rule that affects it changes, and Team emails you the day it does.